- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-733/17 R: Order of the President of the General Court of 23 November 2018 — GMPO v Commission (Interim relief — Medicinal products for human use — Active substance trientine tetrahydrochloride — Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product — Regulation (EC) No 141/2000 — Application for suspension of operation of a measure — Lack of urgency)
ECLI:EU:UNKNOWN:62017TB0733
62017TB0733
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 44/65
(Case T-733/17 R)
((Interim relief - Medicinal products for human use - Active substance trientine tetrahydrochloride - Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product - Regulation (EC) No 141/2000 - Application for suspension of operation of a measure - Lack of urgency))
(2019/C 44/85)
Language of the case: English
Parties
Applicant: GMP-Orphan (GMPO) (Paris, France) (represented by: M. Demetriou QC, E. Mackenzie, Barrister, L. Tsang and J. Mulryne, Solicitors)
Defendant: European Commission (represented by: K. Petersen and A. Sipos, acting as Agents)
Re:
Application under Articles 278 and 279 TFEU for suspension of operation of Article 5 of Commission Implementing Decision C(2017) 6102 final of 5 September 2017 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ 2004 L 136, p. 1) for ‘Cuprior-trientine’, a medicinal product for human use.
Operative part of the order
1.The application for interim measures is dismissed.
2.The costs are reserved.